3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Implantable Cardioverter Defibrillator
An Implantable Cardioverter Defibrillator (ICD) is a sophisticated medical device designed to monitor and regulate heart rhythm in individuals at risk of life-threatening arrhythmias. Implanted beneath the skin, typically near the collarbone, the ICD continuously monitors the heart's electrical activity. In the event of a dangerous arrhythmia, the device delivers precisely timed electrical shocks to restore a normal heart rhythm. This crucial intervention can be lifesaving for individuals with conditions such as ventricular tachycardia or ventricular fibrillation. Additionally, modern ICDs often incorporate pacemaker functionality, further assisting in maintaining a steady heart rate. The ICD's capability to provide both defibrillation and pacing makes it a versatile and vital tool in the management of certain cardiac conditions, enhancing the overall quality of life for those at risk of severe arrhythmias.
Yong Xiao Wang
Albany Medical College, United States
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Federico Benetti
Benetti Foundation, Argentina
Johannes Bonatti
University of Pittsburgh, United States
Eric J Lehr
Cherry Hill Campus, United States
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian FederationSubmit your abstract Today
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Comprehensive surgical revascularization for rapidly worsening ischemic heart failure
Deepak Puri, Max Healthcare, India